A new type of modified Essix Retainer for anterior open bite retention.

The most problematic malocclusion type to retain is anterior open bite although many classical retention appliances are known. The difficulty of maintaining the occlusion arises from the lack of control over the tongue behavior and posture in open bite cases. In the current article, a 2 year follow-up of 2 open-bite patients who were retained with a new type of retention appliance, successfully, were presented.

Synthesis, spectroscopic, structural characterization, electrochemical and antimicrobial activity studies of the Schiff base ligand and its transition metal complexes.

In this study, the Schiff base ligand trans-N,N'-bis[(2,4-dichlorophenyl) methylidene] cyclohexane-1,2-diamine (L) and its copper(II), nickel(II) and palladium(II) transition metal complexes were prepared and characterized by the analytical and spectroscopic methods. The (1)H((13)C) NMR spectra of the ligand and its diamagnetic complexes were recorded in DMSO-d(6) solvent and obtained data confirm that the nitrogen atoms of the imine groups coordinated to the metal ions. Electrochemical properties of the ligand and its metal complexes were investigated in the DMF solvent at the 100 and 250 mVs(-1) scan rates.

New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.

A new series of pyrazoline derivatives were prepared starting from a quinazolinone ring and evaluated for antidepressant, anxiogenic and MAO-A and -B inhibitory activities by in vivo and in vitro tests, respectively. Most of the synthesized compounds showed high activity against both the MAO-A (compounds 4a-4h, 4j-4n, and 5g-5l) and the MAO-B (compounds 4i and 5a-5f) isoforms. However, none of the novel compounds showed antidepressant activity except for 4b.

Synthesis and antimicrobial activity of some new thiazolyl thiazolidine-2,4-dione derivatives.

In this study, a series of thiazolyl thiazolidine-2,4-dione derivatives (Va-f and VIa-f) were synthesized and evaluated for their antibacterial and antifungal activities against Staphylococcus aureus (ATCC 25923), methicillin resistant S. aureus (MRSA ATCC 43300), methicillin resistant S. aureus (MRSA isolate), and Escherichia coli (ATCC 23556) and C.

A new therapeutic approach in Alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics.

The increasing life expectancy in our population makes Alzheimer's disease (AD) a growing public health problem. There is a great need to find a way to prevent and delay the disease. It was shown that monoamine oxidase-B (MAO-B) inhibitors and antiinflammatory agents might be effective in treating AD.